Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2723 | 2088 | 29.6 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
928 | 10457 | CONGENITAL ADRENAL HYPERPLASIA//21 HYDROXYLASE DEFICIENCY//CYP21A2 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CONGENITAL ADRENAL HYPERPLASIA | Author keyword | 420 | 59% | 23% | 477 |
2 | 21 HYDROXYLASE DEFICIENCY | Author keyword | 329 | 82% | 9% | 193 |
3 | CYP21A2 | Author keyword | 122 | 86% | 3% | 62 |
4 | 11 BETA HYDROXYLASE DEFICIENCY | Author keyword | 52 | 87% | 1% | 26 |
5 | STEROID 21 HYDROXYLASE DEFICIENCY | Author keyword | 49 | 94% | 1% | 17 |
6 | CYP21 | Author keyword | 38 | 69% | 2% | 33 |
7 | CAH | Author keyword | 38 | 62% | 2% | 40 |
8 | CYP21A2 GENE | Author keyword | 38 | 93% | 1% | 14 |
9 | 21 HYDROXYLASE | Author keyword | 38 | 55% | 2% | 47 |
10 | 17 HYDROXYPROGESTERONE | Author keyword | 34 | 50% | 2% | 49 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CONGENITAL ADRENAL HYPERPLASIA | 420 | 59% | 23% | 477 | Search CONGENITAL+ADRENAL+HYPERPLASIA | Search CONGENITAL+ADRENAL+HYPERPLASIA |
2 | 21 HYDROXYLASE DEFICIENCY | 329 | 82% | 9% | 193 | Search 21+HYDROXYLASE+DEFICIENCY | Search 21+HYDROXYLASE+DEFICIENCY |
3 | CYP21A2 | 122 | 86% | 3% | 62 | Search CYP21A2 | Search CYP21A2 |
4 | 11 BETA HYDROXYLASE DEFICIENCY | 52 | 87% | 1% | 26 | Search 11+BETA+HYDROXYLASE+DEFICIENCY | Search 11+BETA+HYDROXYLASE+DEFICIENCY |
5 | STEROID 21 HYDROXYLASE DEFICIENCY | 49 | 94% | 1% | 17 | Search STEROID+21+HYDROXYLASE+DEFICIENCY | Search STEROID+21+HYDROXYLASE+DEFICIENCY |
6 | CYP21 | 38 | 69% | 2% | 33 | Search CYP21 | Search CYP21 |
7 | CAH | 38 | 62% | 2% | 40 | Search CAH | Search CAH |
8 | CYP21A2 GENE | 38 | 93% | 1% | 14 | Search CYP21A2+GENE | Search CYP21A2+GENE |
9 | 21 HYDROXYLASE | 38 | 55% | 2% | 47 | Search 21+HYDROXYLASE | Search 21+HYDROXYLASE |
10 | 17 HYDROXYPROGESTERONE | 34 | 50% | 2% | 49 | Search 17+HYDROXYPROGESTERONE | Search 17+HYDROXYPROGESTERONE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STEROID 21 HYDROXYLASE DEFICIENCY | 272 | 71% | 11% | 220 |
2 | 21 HYDROXYLASE DEFICIENCY | 205 | 43% | 18% | 366 |
3 | DISEASE MANIFESTATION | 154 | 92% | 3% | 60 |
4 | CONGENITAL ADRENAL HYPERPLASIA | 144 | 25% | 24% | 499 |
5 | CYP21 | 134 | 86% | 3% | 68 |
6 | MOLECULAR GENOTYPE | 114 | 93% | 2% | 42 |
7 | STEROID 21 HYDROXYLASE | 78 | 55% | 5% | 99 |
8 | REST TUMORS | 73 | 85% | 2% | 39 |
9 | 17 HYDROXYPROGESTERONE LEVELS | 67 | 89% | 1% | 31 |
10 | CYP21 GENE | 67 | 89% | 1% | 31 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Congenital adrenal hyperplasia | 2003 | 329 | 80 | 81% |
Congenital adrenal hyperplasia | 2005 | 242 | 124 | 71% |
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency | 2000 | 566 | 475 | 59% |
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency | 2011 | 27 | 88 | 88% |
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update | 2012 | 13 | 47 | 89% |
Neonatal screening for congenital adrenal hyperplasia | 2009 | 40 | 62 | 81% |
Treatment and health outcomes in adults with congenital adrenal hyperplasia | 2014 | 3 | 81 | 77% |
Clinical outcomes in the management of congenital adrenal hyperplasia | 2012 | 11 | 149 | 80% |
Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency | 2004 | 82 | 110 | 75% |
NONCLASSIC ADRENAL-HYPERPLASIA - CURRENT CONCEPTS | 1994 | 159 | 12 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADRENAL STEROID DISORDERS PROGRAM | 13 | 69% | 0.5% | 11 |
2 | PAEDIAT ENDOCRINOL 833 | 6 | 100% | 0.2% | 4 |
3 | YUAN SHAN | 4 | 39% | 0.4% | 9 |
4 | DISCIPLINA ENDOCRINOL HORMONIOS GENET MOL | 3 | 100% | 0.1% | 3 |
5 | ENDOCRINOL INFANTILE | 3 | 100% | 0.1% | 3 |
6 | ENDOCRINOL MOL MALAD RA | 2 | 38% | 0.2% | 5 |
7 | ENDOCRINOLUNIDAD ENDOCRINOL DESENVOLVIMENTO | 2 | 67% | 0.1% | 2 |
8 | FDN PUBL GALLEGA MED GENOM | 2 | 67% | 0.1% | 2 |
9 | MED GEN EXPTL PATHOL MOLEC BIOL | 2 | 67% | 0.1% | 2 |
10 | PAEDIAT ENDOCRINOL DIABET METAB DIS | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000171996 | MRC MOLEC ENDOCRINOL GRP//3 BETA HYDROXYSTEROID DEHYDROGENASE//HSD3B2 GENE |
2 | 0.0000141887 | 17 ALPHA HYDROXYLASE 17 20 LYASE DEFICIENCY//17 ALPHA HYDROXYLASE DEFICIENCY//ADRENARCHE |
3 | 0.0000119794 | DISORDERS OF SEX DEVELOPMENT//INTERSEX//FEMINIZING GENITOPLASTY |
4 | 0.0000102402 | HIRSUTISM//IDIOPATHIC HIRSUTISM//3 ALPHA ANDROSTANEDIOL GLUCURONIDE |
5 | 0.0000083441 | DETECTION ORIENTED DERIVATIZATION//ISOTOPE CODED DERIVATIZATION//DEUTERATED STEROIDS |
6 | 0.0000058054 | C2 DEFICIENCY//COMPLEMENT GENETICS//COMPLEMENT AND INFLAMMATION |
7 | 0.0000053062 | HYPERREACTIO LUTEINALIS//PREGNANCY LUTEOMA//THECA LUTEIN CYSTS |
8 | 0.0000050623 | 19 NORDEOXYCORTICOSTERONE//ADRENAL RENAL PORTAL CIRCULATION//19 NORALDOSTERONE |
9 | 0.0000044957 | PSEUDOHYPOALDOSTERONISM//TRANSIENT PSEUDOHYPOALDOSTERONISM//PSEUDOHYPOALDOSTERONISM TYPE I |
10 | 0.0000044808 | CHRONIC LUNG DISEASE//POSTNATAL STEROIDS//EARLY DEXAMETHASONE THERAPY |